Search

The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.

… Thursday, November 2, 2017 Summary A new technique allows scientists to see macrophages in tumors by the way they concentrate iron. Macrophages, a type of immune cell, can influence how well a person fares on cancer treatment . The technique is noninvasive and could one day help doctors tailor treatments

MSK's experts in molecular pathology are finding new clues about these tumors.

… Tuesday, July 31, 2018 Summary Sarcomas make up only about 1% of all cancers, yet there are more than 50 different types. Receiving a diagnosis of sarcoma can be overwhelming. But it can be especially confusing because many people have never heard of sarcoma and many doctors have never treated it. It

Learn what to expect from early menopause.

… Thursday, August 16, 2018 Summary Women undergoing procedures for cancer prevention or treatment may begin menopause earlier than other women. Here is a primer on what they can expect. Ovaries may be small, but they pack a powerful punch. These grape-size organs secrete hormones, produce and house eggs

MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.

… Friday, January 17, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis

Hedvig Hricak, Chair of Memorial Sloan Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.

… Monday, February 1, 2010 Summary Hedvig Hricak, Chair of Memorial Sloan Kettering’s Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors. Hedvig Hricak , Chair of Memorial Sloan

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.

… Friday, December 13, 2019 At the annual San Antonio Breast Cancer Symposium, MSK investigators presented the latest research on detection and screening methods for people at high risk; immunotherapy for breast cancer; and the underlying causes of resistance to targeted therapies, among other topics.

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:

… Friday, August 15, 2025 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:  MSK’s financial performance for the first half of 2025 resulted in a deficiency of operating revenues over expenses of $(113.2) million

Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.

… Tuesday, May 31, 2022 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, June 3

The Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center's Gerstner Sloan Kettering Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI's Med into Grad Initiative.

… Monday, November 30, 2009 In November the Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center’s Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI’s Med into Grad Initiative

President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board. Memorial Sloan Kettering Cancer Center’s Luis Alberto Diaz, Jr., MD, was among those appointed.

… Thursday, September 16, 2021 President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board, which plays an important role in guiding the Director of the National Cancer Institute in setting the course for the national cancer research